• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. BIOGLUE SURGICAL ADHESIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. BIOGLUE SURGICAL ADHESIVE Back to Search Results
Model Number BG3510-5-J
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Rupture (2208)
Event Type  Injury  
Event Description
According to the report, bioglue was used approximately one year ago (around (b)(6) 2013) in a "replacement ascending aorta surgery" procedure for type a acute ascending aorta dissection.Bioglue was applied to the proximal and distal suture lines and proximal and distal false lumen.The amount of bioglue applied per site is unknown.It is also unknown if other materials were used for reinforcement, if the target field was dry, if the vessel or graft was clamped and depressurized, and the condition of the native tissue is unknown.Bioglue was used as an adjunct to sutures, but the suturing technique is unknown.Bioglue was not used in a contaminated or infected area.A ct scan showed false aneurysm at the end of august."false aneurysm (rupture) was recognized distal of ascending aorta that bioglue was applied in initial procedure." the patient is under observation; re-procedure was not conducted because the patient has the patient's family does not wish for a re-procedure.
 
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
 
Manufacturer Narrative
According to the report, bioglue was used approximately one year ago (around (b)(6) 2013) in a "replacement ascending aorta surgery" procedure for type a acute ascending aorta dissection.Bioglue was applied to the proximal and distal suture lines and proximal and distal false lumen.The amount of bioglue applied per site is unknown.It is also unknown if other materials were used for reinforcement, if the target field was dry, if the vessel or graft was clamped and depressurized, and the condition of the native tissue is unknown.Bioglue was used as an adjunct to sutures, but the suturing technique is unknown.Bioglue was not used in a contaminated or infected area.A ct scan showed false aneurysm at the end of (b)(6)."false aneurysm (rupture) was recognized distal of ascending aorta that bioglue was applied in initial procedure." the patient is under observation; re-procedure was not conducted because the patient has the patient's family does not wish for a re-procedure.No further information was available.Records were reviewed for possible lot numbers and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.A review was performed of the available information.Based on the information available at the time of this report, a cause of the "false aneurysm (rupture)" observed in the patient could not definitively be determined.The description of the event that actually occurred is unclear as survival from a rupture is not typical.Much information is unknown about the use of bioglue, including the amount of bioglue applied, the condition of the tissue/tissue integrity prior to bioglue application and following the observed event, whether or not the field was properly prepared prior to bioglue application, whether or not the syringe was properly prepared, whether or not the patient had underlying conditions that may have contributed to the event, the suturing technique used, or if other adjunctive measures/products were employed or used.A ct was performed, but the imaging has not been made available for review.Because a reoperation has not been performed, and likely will not be performed, no pathological examination has been conducted.The complainant states that the location of the "false aneurysm (rupture)" was "distal of ascending aorta that bioglue was applied in initial procedure." it is assumed that this is intended to mean that the false aneurysm was observed in the ascending aorta, distal to the location of the application of bioglue in the initial procedure.Based on this information, it is not likely that bioglue caused or contributed to the formation of the false aneurysm in this patient.
 
Event Description
According to the report, bioglue was used approximately one year ago (around (b)(6)2013) in a "replacement ascending aorta surgery" procedure for type a acute ascending aorta dissection.Bioglue was applied to the proximal and distal suture lines and proximal and distal false lumen.The amount of bioglue applied per site is unknown.It is also unknown if other materials were used for reinforcement, if the target field was dry, if the vessel or graft was clamped and depressurized, and the condition of the native tissue is unknown.Bioglue was used as an adjunct to sutures, but the suturing technique is unknown.Bioglue was not used in a contaminated or infected area.A ct scan showed false aneurysm at the end of (b)(6)."false aneurysm (rupture) was recognized distal of ascending aorta that bioglue was applied in initial procedure." the patient is under observation; re-procedure was not conducted because the patient has the patient's family does not wish for a re-procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOGLUE SURGICAL ADHESIVE
Type of Device
SURGICAL ADHESIVE
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key4131351
MDR Text Key18873588
Report Number1063481-2014-00042
Device Sequence Number1
Product Code MUQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P010003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/26/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/01/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberBG3510-5-J
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/26/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-